Boehringer Ingelheim has launched HepCRedefined.com, an online portal to help improve the lives of those living with the hepatitis C virus (HCV) through education, information and understanding. The portal aims to redefine the HCV journey by providing downloadable and shareable resources to healthcare providers, advocates, caregivers and patients.

In order to bring together information that is most relevant to those impacted by HCV, HepCRedefined.com was developed in close collaboration with HCV community advocates as well as healthcare practitioners who are currently treating HCV patients. Resources available on the portal can be shared via social media channels, embedded on other web sources and viewed on various smart devices.

"The entire HCV community is in need of simple tools and resources to talk about the disease in an informed, supportive way. There is information about HCV across the web, but HepCRedefined.com is designed to aggregate straightforward and accurate information in a single virtual destination," said Michael Ninburg, executive director, Hepatitis Education Project. "I'm proud to have contributed to the development of HepCRedefined.com and look forward to working with other advocates to reach communities nationwide."

HepCRedefined.com offers tips and tools to facilitate discussion about HCV, including:

• A video series for healthcare providers offering tips on support sources, clinic program highlights and patient diaries
• A comprehensive and interactive checklist tool to help patients manage considerations of being in care and getting ready for treatment
• A frequently asked questions section about the spread of HCV
• A key facts page about HCV mortality
• A page featuring multiple at-a-glance information cards covering topics about patients and the disease itself designed to help debunk myths surrounding HCV
• A community "C Pledge" where healthcare providers, patients and caregivers can take an oath to redefine the patient journey and the way HCV is perceived

"Boehringer Ingelheim understands that the HCV journey can be a difficult process for patients, caregivers, healthcare providers and advocates alike," said Steve Smith, vice president of established brands, Boehringer Ingelheim. "Through our work with the HCV community to develop HepCRedefined.com, we hope to offer support to the many individuals impacted by HCV with useful information and interactive resources that are easy to find.”

Smith added, “The more we empower ourselves to learn about the challenges associated with HCV, the better we will be able to provide patient management and come closer to a cure for this disease."